{"id":"https://openalex.org/W7143375909","doi":"https://doi.org/10.1159/000551630","title":"A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma","display_name":"A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma","publication_year":2026,"publication_date":"2026-03-30","ids":{"openalex":"https://openalex.org/W7143375909","doi":"https://doi.org/10.1159/000551630","pmid":"https://pubmed.ncbi.nlm.nih.gov/42131624"},"language":"en","primary_location":{"id":"doi:10.1159/000551630","doi":"https://doi.org/10.1159/000551630","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000551630","pdf_url":"https://karger.com/lic/article-pdf/doi/10.1159/000551630/4523387/000551630.pdf","source":{"id":"https://openalex.org/S2764970739","display_name":"Liver Cancer","issn_l":"1664-5553","issn":["1664-5553","2235-1795"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Liver Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://karger.com/lic/article-pdf/doi/10.1159/000551630/4523387/000551630.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013744957","display_name":"Anthony B. El-Khoueiry","orcid":"https://orcid.org/0000-0002-9053-3841","observed_orcids":["https://orcid.org/0000-0002-9053-3841"]},"institutions":[{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony B. El-Khoueiry","raw_affiliation_strings":["University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210117038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012289008","display_name":"Christopher Hanyoung Lieu","orcid":"https://orcid.org/0000-0002-4852-4642","observed_orcids":["https://orcid.org/0000-0002-4852-4642"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher H. Lieu","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO, USA","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081273660","display_name":"Ghassan K. Abou\u2010Alfa","orcid":"https://orcid.org/0000-0002-1522-8054","observed_orcids":["https://orcid.org/0000-0002-1522-8054"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]},{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["IE","US"],"is_corresponding":false,"raw_author_name":"Ghassan K. Abou-Alfa","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA","Trinity College Dublin, Dublin, Ireland","Weill Medical College at Cornell University, New York, NY, USA"],"raw_orcid":"https://orcid.org/0000-0002-1522-8054","affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Trinity College Dublin, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468"]},{"raw_affiliation_string":"Weill Medical College at Cornell University, New York, NY, USA","institution_ids":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044840107","display_name":"Apostolia Maria Tsimberidou","orcid":"https://orcid.org/0000-0003-2713-233X","observed_orcids":["https://orcid.org/0000-0003-2713-233X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Apostolia M. Tsimberidou","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101638085","display_name":"Daruka Mahadevan","orcid":"https://orcid.org/0000-0002-7129-5593","observed_orcids":["https://orcid.org/0000-0002-7129-5593"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daruka Mahadevan","raw_affiliation_strings":["The University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA","institution_ids":["https://openalex.org/I165951966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102929792","display_name":"Diana L. Hanna","orcid":"https://orcid.org/0000-0003-2681-5032","observed_orcids":["https://orcid.org/0000-0003-2681-5032"]},"institutions":[{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana L. Hanna","raw_affiliation_strings":["University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210117038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068892140","display_name":"Bruno Bockorny","orcid":"https://orcid.org/0000-0002-9162-1560","observed_orcids":["https://orcid.org/0000-0002-9162-1560"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruno Bockorny","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004799762","display_name":"Breelyn Ann Wilky","orcid":"https://orcid.org/0000-0001-5080-497X","observed_orcids":["https://orcid.org/0000-0001-5080-497X"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Breelyn A. Wilky","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO, USA","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122792701","display_name":"Alexis Diane Leal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexis Leal","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO, USA","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079409805","display_name":"Justin Stebbing","orcid":"https://orcid.org/0000-0002-1117-6947","observed_orcids":["https://orcid.org/0000-0002-1117-6947"]},"institutions":[{"id":"https://openalex.org/I51216347","display_name":"Anglia Ruskin University","ror":"https://ror.org/0009t4v78","country_code":"GB","type":"education","lineage":["https://openalex.org/I51216347"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Justin Stebbing","raw_affiliation_strings":["Anglia Ruskin University, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anglia Ruskin University, Cambridge, UK","institution_ids":["https://openalex.org/I51216347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047404175","display_name":"Manushak Avagyan","orcid":"https://orcid.org/0000-0003-2207-3107","observed_orcids":["https://orcid.org/0000-0003-2207-3107"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manushak Avagyan","raw_affiliation_strings":["Agenus Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130952654","display_name":"Wei Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Wu","raw_affiliation_strings":["Agenus Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080150466","display_name":"Dhan Sidhartha Chand","orcid":"https://orcid.org/0009-0003-8124-4399","observed_orcids":["https://orcid.org/0009-0003-8124-4399"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dhan Chand","raw_affiliation_strings":["Agenus Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073582280","display_name":"Joseph Elan Grossman","orcid":"https://orcid.org/0000-0002-2130-2783","observed_orcids":["https://orcid.org/0000-0002-2130-2783"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph E. Grossman","raw_affiliation_strings":["Agenus Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010363210","display_name":"Benny Johnson","orcid":"https://orcid.org/0000-0003-3683-8115","observed_orcids":["https://orcid.org/0000-0003-3683-8115","https://orcid.org/0000-0002-6826-6687"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benny Johnson","raw_affiliation_strings":["Agenus Inc, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc, Lexington, MA, USA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071193838","display_name":"Andrea J. Bullock","orcid":"https://orcid.org/0000-0001-7143-0225","observed_orcids":["https://orcid.org/0000-0001-7143-0225"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea J. Bullock","raw_affiliation_strings":["Beth Israel Deaconess Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beth Israel Deaconess Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3590,"currency":"USD","value_usd":3590},"apc_paid":{"value":3590,"currency":"USD","value_usd":3590},"fwci":2.7783,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.88897572,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6499000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6499000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.34860000014305115,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/botensilimab","display_name":"botensilimab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/balstilimab","display_name":"balstilimab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.8199999928474426},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9739999771118164},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7429999709129333},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/treatment-refractory-cancer","display_name":"treatment-refractory cancer","score":0.8090000152587891},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.7429999709129333},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9480000138282776},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9079999923706055},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7099999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.843999981880188},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9050999879837036},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7746000289916992},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6381000280380249},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5997999906539917},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5954999923706055},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.5871000289916992},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5360000133514404},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.5203999876976013},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5016000270843506},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4869999885559082},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4553999900817871},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.43459999561309814},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4065999984741211},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.3783000111579895},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36890000104904175},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3617999851703644},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.3366999924182892},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.3230000138282776},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.3206999897956848},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31360000371932983},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.2793999910354614},{"id":"https://openalex.org/C2987315675","wikidata":"https://www.wikidata.org/wiki/Q1773974","display_name":"Disease control","level":2,"score":0.27480000257492065},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2630999982357025},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.25940001010894775},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.2540999948978424},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25290000438690186}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1159/000551630","doi":"https://doi.org/10.1159/000551630","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000551630","pdf_url":"https://karger.com/lic/article-pdf/doi/10.1159/000551630/4523387/000551630.pdf","source":{"id":"https://openalex.org/S2764970739","display_name":"Liver Cancer","issn_l":"1664-5553","issn":["1664-5553","2235-1795"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Liver Cancer","raw_type":"journal-article"},{"id":"pmid:42131624","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42131624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Liver cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13167118","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42131624/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Liver Cancer","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1159/000551630","doi":"https://doi.org/10.1159/000551630","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000551630","pdf_url":"https://karger.com/lic/article-pdf/doi/10.1159/000551630/4523387/000551630.pdf","source":{"id":"https://openalex.org/S2764970739","display_name":"Liver Cancer","issn_l":"1664-5553","issn":["1664-5553","2235-1795"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Liver Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8173732757568359,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320309165","display_name":"FibroGen","ror":"https://ror.org/03sxe1905"},{"id":"https://openalex.org/F4320310276","display_name":"Helsinn","ror":"https://ror.org/01kdzkq48"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320312140","display_name":"Exelixis","ror":"https://ror.org/01e3jga91"},{"id":"https://openalex.org/F4320313690","display_name":"Novocure","ror":"https://ror.org/018ec2p66"},{"id":"https://openalex.org/F4320314605","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38"},{"id":"https://openalex.org/F4320315119","display_name":"Parker Institute for Cancer Immunotherapy","ror":"https://ror.org/0184qbg02"},{"id":"https://openalex.org/F4320316469","display_name":"Atara Biotherapeutics","ror":"https://ror.org/04h82wq77"},{"id":"https://openalex.org/F4320317235","display_name":"BeiGene","ror":"https://ror.org/012v2c923"},{"id":"https://openalex.org/F4320318921","display_name":"Revolution Medicines","ror":"https://ror.org/00mny1y94"},{"id":"https://openalex.org/F4320319264","display_name":"MacroGenics","ror":"https://ror.org/01hcd4187"},{"id":"https://openalex.org/F4320319694","display_name":"Springworks Therapeutics","ror":"https://ror.org/0466xvm69"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320325394","display_name":"Ministry of Minority Affairs","ror":"https://ror.org/050kded90"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320328455","display_name":"Ipsen","ror":"https://ror.org/00d801g55"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7143375909.pdf","grobid_xml":"https://content.openalex.org/works/W7143375909.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"Botensilimab":[1],"(BOT)":[2],"is":[3,74],"a":[4,50,348],"fragment":[5],"crystallizable":[6],"(Fc)-enhanced":[7],"multifunctional":[8],"anti-cytotoxic":[9],"T-lymphocyte-associated":[10],"antigen":[11],"4":[12],"(CTLA-4)":[13],"antibody":[14],"with":[15,30,70,86,93,103,113,130,251,311,315,333],"differentiated":[16],"mechanisms":[17],"of":[18,54,82,110,174,295,331,344],"action,":[19],"designed":[20],"to":[21,24,146,160],"extend":[22],"therapy":[23],"cold/poorly":[25],"immunogenic":[26],"solid":[27,88],"tumors.":[28,89],"Patients":[29,129],"hepatocellular":[31],"carcinoma":[32],"(HCC)":[33],"who":[34,115],"progress":[35],"on":[36,117],"or":[37,118,137,213,216,290],"after":[38,119],"first-line":[39],"immunotherapy":[40,121],"have":[41],"limited":[42],"treatment":[43],"options.":[44],"Here,":[45],"we":[46],"report":[47],"findings":[48],"from":[49],"phase":[51,78],"1b":[52],"study":[53,81,91],"BOT":[55,133],"plus":[56,149],"balstilimab":[57],"(BAL;":[58],"anti-programmed":[59],"cell":[60],"death":[61],"protein":[62],"1":[63,136],"[PD-1]":[64],"antibody)":[65],"in":[66,84,126,308,320,347],"previously":[67,313],"treated":[68,314],"patients":[69,85,112,192,242,310,332],"HCC.":[71],"Methods:":[72],"This":[73],"an":[75,184],"open-label,":[76],"nonrandomized,":[77],"1b,":[79],"multicenter":[80],"BOT\u00b1BAL":[83],"advanced":[87],"The":[90,256,299],"began":[92],"dose":[94,101],"escalation":[95],"(3":[96],"+":[97],"3":[98,152,267,274,283],"design)":[99],"then":[100],"expansion":[102],"multiple":[104],"disease-specific":[105],"cohorts.":[106],"An":[107],"expanded":[108],"cohort":[109],"19":[111],"HCC":[114,131,312],"progressed":[116],"prior":[120],"(primarily":[122],"atezolizumab/bevacizumab)":[123],"are":[124],"included":[125,164,261],"this":[127],"analysis.":[128],"received":[132],"intravenously":[134,151],"at":[135],"2":[138,147,156,161,336],"mg/kg":[139,153],"once":[140,154],"every":[141,155],"6":[142],"weeks":[143],"for":[144,158],"up":[145,159],"years":[148],"BAL":[150],"weeks,":[157],"years.":[162],"Endpoints":[163],"safety,":[165],"objective":[166],"response":[167,215],"rate":[168,210],"(ORR),":[169],"disease":[170,350],"control":[171],"rate,":[172],"duration":[173],"response,":[175],"and":[176,206,232,276,305,328],"progression-free":[177],"survival":[178,181],"(PFS).":[179],"Overall":[180],"(OS)":[182],"was":[183,200,226,235],"exploratory":[185],"endpoint.":[186],"Results:":[187],"Among":[188],"18":[189],"efficacy":[190],"evaluable":[191],"(with":[193],"\u22651":[194],"post-baseline":[195],"6-week":[196],"imaging":[197],"scan),":[198],"ORR":[199],"17%":[201],"(3/18;":[202],"95%":[203,221],"CI:":[204,222,230,239],"4-41),":[205],"18-week":[207],"clinical":[208],"benefit":[209],"(a":[211],"complete":[212],"partial":[214],"stable":[217],"disease)":[218],"50%":[219],"(9/18;":[220],"26-74).":[223],"Median":[224],"PFS":[225],"4.4":[227],"months":[228,237],"(95%":[229,238],"1.4-6.9),":[231],"median":[233],"OS":[234],"12.3":[236],"8.4-21.4).":[240],"Thirteen":[241],"(68%)":[243],"experienced":[244],"any-grade":[245],"immune-mediated":[246,259],"treatment-related":[247,288],"adverse":[248],"events":[249,278],"(TRAEs),":[250],"37%":[252],"(7/19)":[253],"grade":[254,266,273,282,335],"3.":[255],"most":[257],"common":[258],"TRAEs":[260],"diarrhea/colitis":[262],"(37%":[263],"[7/19];":[264],"16%":[265,272],"[3/19]),":[268,275],"hepatitis":[269],"(21%":[270,279],"[4/19];":[271,280],"dermatologic":[277],"5%":[281],"[1/19]).":[284],"There":[285],"were":[286],"no":[287],"deaths":[289],"new":[291],"safety":[292,307],"signals":[293],"outside":[294],"the":[296,324],"class.":[297],"Conclusions:":[298],"BOT+BAL":[300],"combination":[301],"demonstrated":[302],"durable":[303],"responses":[304],"manageable":[306],"treatment-refractory":[309],"immunotherapy,":[316],"supporting":[317],"further":[318],"investigation":[319],"randomized":[321],"studies.":[322],"Despite":[323],"small":[325],"sample":[326],"size":[327],"high":[329],"percentage":[330],"albumin-bilirubin":[334],"liver":[337],"disease,":[338],"these":[339],"results":[340],"provide":[341],"early":[342],"evidence":[343],"antitumor":[345],"activity":[346],"difficult-to-treat":[349],"setting.":[351]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2026-03-31T00:00:00"}